These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34078649)

  • 1. The utility of platelet inhibition testing in patients undergoing Pipeline embolization of intracranial aneurysms.
    Miller TR; Wessell A; Jindal G; Malhotra A; Simard JM; Gandhi D
    J Neurointerv Surg; 2022 Jan; 14(1):. PubMed ID: 34078649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2Y12 hyporesponse (PRU>200) is not associated with increased thromboembolic complications in anterior circulation Pipeline.
    Bender MT; Lin LM; Colby GP; Lubelski D; Huang J; Tamargo RJ; Coon AL
    J Neurointerv Surg; 2017 Oct; 9(10):978-981. PubMed ID: 27599997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet Function Testing with a VerifyNow-Directed Personalized Antiplatelet Strategy and Associated Rates of Thromboembolic Complications After Pipeline Embolization for Complex Cerebral Aneurysms.
    Neyens R; Donaldson C; Andrews C; Kellogg R; Spiotta A
    World Neurosurg; 2020 Jun; 138():e674-e682. PubMed ID: 32194270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive platelet inhibition following Pipeline embolization of intracranial aneurysms.
    Miller TR; Khunte M; Caffes N; Anders M; Rock P; Beitelshees AL; Malhotra A; Cannarsa G; Cherian J; Simard JM; Jindal G; Gandhi D
    J Neurointerv Surg; 2023 Aug; 15(8):741-746. PubMed ID: 35728944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow diversion with the pipeline embolization device for patients with intracranial aneurysms and antiplatelet therapy: A systematic literature review.
    Texakalidis P; Bekelis K; Atallah E; Tjoumakaris S; Rosenwasser RH; Jabbour P
    Clin Neurol Neurosurg; 2017 Oct; 161():78-87. PubMed ID: 28863286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining a Clopidogrel Response Cut-Off Value Using Light Transmission Aggregometry Before Pipeline Embolization of Unruptured Intracranial Aneurysms.
    Adeeb N; Gupta R; Schneider AM; Leadon M; Enriquez A; Griessenauer CJ; Salem M; Alturki A; Schmalz P; Ogilvy CS; Thomas AJ; Moore JM
    World Neurosurg; 2018 May; 113():e146-e152. PubMed ID: 29425984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiplatelet therapy on thromboembolism after flow diversion with the pipeline embolization device.
    Heller RS; Dandamudi V; Lanfranchi M; Malek AM
    J Neurosurg; 2013 Dec; 119(6):1603-10. PubMed ID: 23971953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures.
    Nakagawa I; Park HS; Yokoyama S; Wada T; Hironaka Y; Motoyama Y; Takayama K; Kichikawa K; Nakase H
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):163-71. PubMed ID: 26493334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study.
    Adeeb N; Griessenauer CJ; Foreman PM; Moore JM; Shallwani H; Motiei-Langroudi R; Alturki A; Siddiqui AH; Levy EI; Harrigan MR; Ogilvy CS; Thomas AJ
    Stroke; 2017 May; 48(5):1322-1330. PubMed ID: 28411263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device.
    McTaggart RA; Choudhri OA; Marcellus ML; Brennan T; Steinberg GK; Dodd RL; Do HM; Marks MP
    J Neurointerv Surg; 2015 Jun; 7(6):425-30. PubMed ID: 24739599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy-Mediated Antiplatelet Management Protocol Compared to One-time Platelet Function Testing Prior to Pipeline Embolization of Cerebral Aneurysms: A Propensity Score-Matched Cohort Study.
    Griessenauer CJ; Jain A; Enriquez-Marulanda A; Gupta R; Adeeb N; Moore JM; Grassi SA; Dalal SS; Ogilvy CS; Thomas AJ; Schirmer CM
    Neurosurgery; 2019 Mar; 84(3):673-679. PubMed ID: 29608747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision of VerifyNow P2Y12 Assessment of Clopidogrel Response in Patients Undergoing Cerebral Aneurysm Flow Diversion.
    Bender MT; Zarrin DA; Campos JK; Jiang B; Chandra A; Vo CD; Caplan JM; Huang J; Tamargo RJ; Lin LM; Colby GP; Coon AL
    Neurosurgery; 2019 Oct; 85(4):543-549. PubMed ID: 30169782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet Therapy and Periprocedural Risk Factor Analysis for Pipeline Embolization Device Treatment of Unruptured Internal Carotid Artery Aneurysms: A Retrospective, Multicenter Analysis.
    Hosoo H; Ishikawa E; Tsuruta W; Sato M; Ito Y; Hayakawa M; Takigawa T; Marushima A; Suzuki K; Hyodo A; Matsumaru Y
    World Neurosurg; 2022 Jan; 157():e102-e110. PubMed ID: 34610445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining complication rates with flow diversion of anterior circulation aneurysms after introduction of the Pipeline Flex: analysis of a single-institution series of 568 cases.
    Colby GP; Bender MT; Lin LM; Beaty N; Caplan JM; Jiang B; Westbroek EM; Varjavand B; Campos JK; Huang J; Tamargo RJ; Coon AL
    J Neurosurg; 2018 Dec; 129(6):1475-1481. PubMed ID: 29327999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device.
    Delgado Almandoz JE; Crandall BM; Scholz JM; Fease JL; Anderson RE; Kadkhodayan Y; Tubman DE
    J Neurointerv Surg; 2013 Nov; 5 Suppl 3():iii3-10. PubMed ID: 23314576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of alternatives to clopidogrel in flow-diversion treatment with the Pipeline embolization device.
    Atallah E; Saad H; Bekelis K; Chalouhi N; Tjoumakaris S; Hasan D; Eller J; Stidd D; Rosenwasser RH; Jabbour P
    J Neurosurg; 2018 Nov; 129(5):1130-1135. PubMed ID: 29219758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: comparing results of the VerifyNow P2Y12 assay to thromboelastography with platelet mapping.
    Corliss BM; Polifka AJ; Harris NS; Hoh BL; Fox WC
    J Neurosurg; 2018 Nov; 129(5):1160-1165. PubMed ID: 29271717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device.
    Delgado Almandoz JE; Crandall BM; Scholz JM; Fease JL; Anderson RE; Kadkhodayan Y; Tubman DE
    AJNR Am J Neuroradiol; 2014 Jan; 35(1):128-35. PubMed ID: 23828107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y
    Kim CH; Hwang G; Kwon OK; Ban SP; Chinh ND; Tjahjadi M; Oh CW; Bang JS; Kim T
    Radiology; 2017 Feb; 282(2):542-551. PubMed ID: 27603789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy and the risk of ischemic and hemorrhagic complications associated with Pipeline embolization of cerebral aneurysms: a systematic review and pooled analysis.
    Saber H; Kherallah RY; Hadied MO; Kazemlou S; Chamiraju P; Narayanan S
    J Neurointerv Surg; 2019 Apr; 11(4):362-366. PubMed ID: 30201813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.